VU534
VU534 is a NAPE-PLD activator, with an EC50 of 0.30 μM. VU534 is dual inhibitors of FAAH and sEH (IC50 of 1.2 μM) . VU534 increases efferocytosis in a NAPE-PLD dependent manner. VU534 has the potential for cardiometabolic diseases study .
Product Specifications
CAS Number
923509-20-0
Purity
>98% (HPLC)
Solubility
In Vitro: DMSO : 25 mg/mL (55.86 mM; Ultrasonic)
Smiles
CC1=CC2=C (SC (NC (=O) C3CCN (CC3) S (=O) (=O) C3=CC=C (F) C=C3) =N2) C (C) =C1
Molecular Formula
C21H22FN3O3S2
Molecular Weight
447.55
Storage Conditions
Storage temperature: -20°C. Stability: ≥ 2 years
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15087138 1 Vial
Lentiviral human RPS14 shRNA (UAS) - Lentiviral human RPS14 shRNA (UAS) (100)
Sign In for Pricing
View Details 
XLD45301-01 100 mg
3- (Pyridin-4-ylamino) propanoic acid hydrochloride
Sign In for Pricing
View Details XLD45301-02 1 g
3- (Pyridin-4-ylamino) propanoic acid hydrochloride
Sign In for Pricing
View Details 